6Phytoestrogens and diseases of the prostate gland

[1]  K. Griffiths,et al.  Possible Relationship between Dietary Factors and Pathogenesis of Prostate Cancer , 1998, International journal of urology : official journal of the Japanese Urological Association.

[2]  C. Huggins,et al.  STUDIES ON PROSTATIC CANCER: II. THE EFFECTS OF CASTRATION ON ADVANCED CARCINOMA OF THE PROSTATE GLAND , 1941 .

[3]  W. Mckeehan,et al.  Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. , 1992, Molecular endocrinology.

[4]  S. Dudek,et al.  Prostatic ductal system in rats: regional variation in morphological and functional activities. , 1990, Biology of reproduction.

[5]  W. Garraway,et al.  High prevalence of benign prostatic hypertrophy in the community , 1991, The Lancet.

[6]  L. Chung,et al.  Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. , 1983, Recent progress in hormone research.

[7]  M. Pike,et al.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males , 1992, The Lancet.

[8]  P. Walsh,et al.  The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.

[9]  T. Stamey,et al.  PATTERNS OF PROGRESSION IN PROSTATE CANCER , 1986, The Lancet.

[10]  K. Griffiths,et al.  The regulation of prostatic growth , 1996 .

[11]  M. Karin,et al.  Negative transcriptional regulation by nuclear receptors. , 1994, Seminars in cancer biology.

[12]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[13]  J. Cummings,et al.  DNA topoisomerase I and II as targets for rational design of new anticancer drugs. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  B. Lytton,et al.  The incidence of benign prostatic obstruction. , 1968, The Journal of urology.

[15]  W. Haenszel,et al.  Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. , 1968, Journal of the National Cancer Institute.

[16]  C. Rice-Evans,et al.  The relative antioxidant activities of plant-derived polyphenolic flavonoids. , 1995, Free radical research.

[17]  J. Deslypere,et al.  A new look to the andropause: altered function of the gonadotrophs. , 1989, Journal of steroid biochemistry.

[18]  L. Denis.  Prostate cancer. Primary hormonal treatment , 1993 .

[19]  G. L. Kenyon,et al.  Design of kinase inhibitors , 1987, Medicinal research reviews.

[20]  M. Shibuya,et al.  Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.

[21]  J. Lin,et al.  Reversion of the transformed phenotypes of v-H-ras NIH3T3 cells by flavonoids through attenuating the content of phosphotyrosine. , 1994, Cancer letters.

[22]  S. Barnes,et al.  Soy intake and cancer risk: a review of the in vitro and in vivo data. , 1994, Nutrition and cancer.

[23]  C. Eaton,et al.  Regulation of prostate growth. , 1991, The Journal of endocrinology.

[24]  H. Adlercreutz,et al.  Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens , 1993, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  H. Guess.  Epidemiology and natural history of benign prostatic hyperplasia. , 1995, The Urologic clinics of North America.

[26]  P. Walsh,et al.  Cancer control following anatomical radical prostatectomy: an interim report. , 1991, The Journal of urology.

[27]  D. Bostwick,et al.  Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.

[28]  S. Orrenius,et al.  Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. , 1993, Biochemical and biophysical research communications.

[29]  A. Vermeulen.  [Metabolic effects of obesity in men]. , 1993, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.

[30]  T. Libermann,et al.  Regulation of cell proliferation by epidermal growth factor. , 1983, CRC critical reviews in biochemistry.

[31]  D. S. Coffey,et al.  Etiology and disease process of benign prostatic hyperplasia , 1989, The Prostate. Supplement.

[32]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[33]  R. Cox,et al.  Status of radiation treatment of prostate cancer at Stanford University. , 1989, NCI monographs : a publication of the National Cancer Institute.

[34]  J. Bishop.  Cellular oncogenes and retroviruses. , 1983, Annual review of biochemistry.

[35]  R. Brown,et al.  Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. , 1980, Journal of the National Cancer Institute.

[36]  P. Boyle,et al.  Screening for prostate cancer--necessity or nonsense? , 1993, European journal of cancer.

[37]  T. Hunter.  Protein-Tryosine Kinases , 1985 .

[38]  B. Henderson,et al.  Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. , 1991, British Journal of Cancer.

[39]  H. Adlercreutz,et al.  Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. , 1986, Journal of steroid biochemistry.

[40]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[41]  H. Adlercreutz,et al.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  G. Fenwick,et al.  Naturally occurring oestrogens in foods--a review. , 1985, Food additives and contaminants.

[43]  P. Boyle,et al.  International trends in prostatic cancer , 1984, International journal of cancer.

[44]  P. Riddle,et al.  A comparative study of the ultrastructure and lack of growth capacity of adult human prostate epithelium mechanically separated from its stroma , 1970, The Journal of pathology.

[45]  R J Glynn,et al.  The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. , 1985, American journal of epidemiology.

[46]  B. Foster,et al.  Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. , 1996, The International journal of developmental biology.

[47]  J. Sjövall,et al.  Soya--a dietary source of the non-steroidal oestrogen equol in man and animals. , 1984, The Journal of endocrinology.

[48]  P. Boyle,et al.  Cancer of the prostate: epidemiology and aetiology. , 1987, British journal of urology.

[49]  K. Griffiths,et al.  Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer. , 1997, European urology.

[50]  S. Dudek,et al.  Prostatic ductal system in rats: regional variation in localization of an androgen-repressed gene product, sulfated glycoprotein-2. , 1991, Endocrinology.

[51]  C. Huggins,et al.  Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.

[52]  J. Folkman,et al.  Toward an Understanding of Angiogenesis: Search and Discovery , 2015, Perspectives in biology and medicine.

[53]  H. Adlercreutz,et al.  Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). , 1987, Journal of steroid biochemistry.

[54]  F. Schröder,et al.  Screening and early detection of prostate cancer , 2000, The Prostate.

[55]  K. Matsumoto,et al.  Genistein arrests cell cycle progression at G2-M. , 1993, Cancer research.

[56]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[57]  H. Bonkhoff,et al.  Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: A stem cell model , 1996, The Prostate.

[58]  K. Griffiths,et al.  The preventive role of diet in prostatic disease. , 1996, British journal of urology.

[59]  R. E. Peterson,et al.  Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male Pseudohermaphroditism , 1974, Science.

[60]  H. Kastendieck.  Correlations between atypical primary hyperplasia and carcinoma of the prostate. A histological study of 180 total prostatectomies. , 1980, Pathology, research and practice.

[61]  M. Barry,et al.  Epidemiology and natural history of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.

[62]  W. McGuire,et al.  Phytoestrogen interaction with estrogen receptors in human breast cancer cells. , 1978, Endocrinology.

[63]  O. Carpén,et al.  Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter-receptors. , 1994, Biochemical and biophysical research communications.

[64]  Louis Denis,et al.  To screen or not to screen? , 1992, The Prostate. Supplement.

[65]  R. Nass,et al.  Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. , 1993, The Journal of clinical endocrinology and metabolism.

[66]  R. Mehta,et al.  Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. , 1995, Journal of natural products.

[67]  J. Rubin,et al.  KGF and EGF differentially regulate the phenotype of prostatic epithelial cells. , 1996, Growth regulation.

[68]  K. Griffiths,et al.  Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. , 1996, British Journal of Cancer.

[69]  J. McNeal.  The zonal anatomy of the prostate , 1981, The Prostate.

[70]  K. Griffiths,et al.  Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. , 1995, The Journal of endocrinology.

[71]  C. Chang,et al.  Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. , 1992, The Journal of urology.

[72]  The Evolution of an Epidemic of Unknown Origin , 1994 .

[73]  L. Chung,et al.  Stromal‐epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme , 1983, The Prostate.

[74]  R J Miksicek,et al.  Commonly occurring plant flavonoids have estrogenic activity. , 1993, Molecular pharmacology.

[75]  A. Bélanger,et al.  Influence of diet on plasma steroid and sex plasma binding globulin levels in adult men , 1989 .

[76]  M. Forsling,et al.  Influence of oxytocin on sodium excretion in the anaesthetized Brattleboro rat. , 1991, The Journal of endocrinology.

[77]  F. Mostofi,et al.  Atypical hyperplasia of prostate. , 1989, Urology.

[78]  E. Huberman,et al.  Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[79]  M. Beato,et al.  Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. , 1993, Endocrine reviews.

[80]  Denis Lj.  Controversies in the management of localized and metastatic prostatic cancer. , 1991 .

[81]  H. Gronemeyer,et al.  Cell‐specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. , 1991, The EMBO journal.

[82]  T. Fleming,et al.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[83]  R. Hoffman,et al.  Genistein inhibits the growth of human‐patient BPH and prostate cancer in histoculture , 1998, The Prostate.

[84]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[85]  W. Sakr.  High-grade prostatic intraepithelial neoplasia: additional links to a potentially more aggressive prostate cancer? , 1998, Journal of the National Cancer Institute.

[86]  E. Scholar,et al.  Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. , 1994, Cancer letters.

[87]  H. Adlercreutz,et al.  Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. , 1986, Journal of Steroid Biochemistry.

[88]  S. Brown,et al.  The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid. , 1992, Biochemical pharmacology.

[89]  K. Yamamoto,et al.  Steroid receptor regulated transcription of specific genes and gene networks. , 1985, Annual review of genetics.

[90]  N. Bruchovsky,et al.  Hormonal effects on cell proliferation in rat prostate. , 1975, Vitamins and hormones.

[91]  D. Bostwick,et al.  Intraductal dysplasia: a premalignant lesion of the prostate. , 1986, Human pathology.

[92]  J. Santibañez,et al.  Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. , 1997, Anticancer research.

[93]  S. Barnes,et al.  Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation , 1993, The Prostate.